| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.095 | 0.05 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.05 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.06 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.06 |